Healthcare Markets: The Evolution of Regulation, Competition, and Innovation
Now more than ever before, not only medical issues but also economic and social issues influence how health care is organized, governed, financed, and delivered.
Our empirical research advances understanding of the economics and regulation of the healthcare industry, with an emphasis on the biopharmaceutical and medical device industries. Faculty researchers examine a variety of issues, most typically around firm, industry, and regulatory organization and performance. Past and ongoing research includes the speed of drug development, sales and promotion strategies during adverse regulatory events, regulatory compliance, healthcare payment reform, and the effect of eHealth on health behaviors and outcomes. Some research projects entail the development and analysis of proprietary data, while others are conducted in collaboration with the U.S. Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC).
“Information or Obfuscation? The case of the “no High Fructose Corn Syrup” label” Stanford GSB Quant Marketing Alumni Conference, Apr 2022
“Debunking Misinformation in Advertising” McDonough School of Business, Georgetown University, Nov 2021
“Industry-funded Research and Bias in Food Science” Mendoza College of Business, University of Notre Dame, Oct 2021
“Recalls and New Product Development: Own Firm Distractions and Competitor Firm Opportunities” University of North Carolina (Kenan-Flagler) Strategy & Entrepreneurship Seminar, 2021 University of Utah (Eccles School of Business) Strategy Seminar (MAR 2020)
“When is Organization Inefficient? A Knowledge-Based Examination in Medical Device Manufacturing,” Industry Studies Association (ISA) Conference (2020)
“Does the Internet Improve Consumer Healthcare Behaviors?” University of Pennsylvania — Leonard Davis Institute Seminar Series (2018)